2003
DOI: 10.1016/s0748-7983(03)00098-2
|View full text |Cite
|
Sign up to set email alerts
|

Pattern of recurrence after surgery in adenocarcinoma of the gastro-oesophageal junction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
29
0
6

Year Published

2004
2004
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 60 publications
(41 citation statements)
references
References 22 publications
6
29
0
6
Order By: Relevance
“…Type I tumor, or adenocarcinoma of the lower esophagus often associated with Barrett's esophagus, according to Siewert's classification (7) was reported to be the most prevalent type in the European institutions (8,9). However, Type III subcardial carcinoma was by far the most common type in Japan (10) as well as in the current study.…”
Section: Discussionsupporting
confidence: 46%
“…Type I tumor, or adenocarcinoma of the lower esophagus often associated with Barrett's esophagus, according to Siewert's classification (7) was reported to be the most prevalent type in the European institutions (8,9). However, Type III subcardial carcinoma was by far the most common type in Japan (10) as well as in the current study.…”
Section: Discussionsupporting
confidence: 46%
“…6,7 When EAC recurs, the anatomic location of recurrence tends to be distant more often than in ESCC. 8,9 Whereas EAC incidence has dramatically increased since 1975 in the United States, ESCC incidence has dropped by half over the same time period. 10 This is one of the largest reported single-institution cohort studies [11][12][13] to describe long-term cancer outcomes for EAC in which patients underwent complete resection of all tumor mostly without perioperative chemotherapy or radiotherapy.…”
Section: © 2010 Mayo Foundation For Medical Education and Researchmentioning
confidence: 99%
“…Surgical resection remains the most important element of a potentially curative treatment. Although the addition of neoadjuvant therapy has shown to improve postoperative survival rates [4,5], the risk of local or distant tumor recurrence remains substantial [6,7,8]. …”
Section: Introductionmentioning
confidence: 99%